Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
iPS Cell Differentiation01:22

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparing national microinvasive glaucoma surgery procedure rates in response to Medicare and industry payment changes.

Ophthalmology. Glaucoma·2026
Same author

Comparative cost-effectiveness of Xen45 Gel Stent versus trabeculectomy in the United States Medicare system.

Ophthalmology. Glaucoma·2026
Same author

Remote Tonometry Identifies Significant Variability in the Timing of Intraocular Pressure Response to Topical Medication Change.

Ophthalmology. Glaucoma·2026
Same author

Outcomes of Ab Interno 63 µm vs. 45 µm XEN<sup>®</sup> Gel Stent in Open-Angle Glaucoma: A Five-Year Follow-Up Study.

Journal of clinical medicine·2026
Same author

The internal limiting basement membrane inhibits functional engraftment of transplanted human retinal ganglion cells in vivo.

Science translational medicine·2026
Same author

Blood flow patterns in mice are regulated by interpericyte tunneling nanotubes connecting functionally-opposite neuronal areas.

Nature communications·2026
Same journal

Approval of retinal gene therapies in the US and Europe based on visual acuity and microperimetry.

Expert review of ophthalmology·2025
Same journal

Infectious etiologies of conjunctival tumors.

Expert review of ophthalmology·2025
Same journal

What will the future role for large language models (LLMs) be in managing patients with glaucoma?

Expert review of ophthalmology·2025
Same journal

Clinical, molecular, and immunologic mechanisms of CMV retinitis: Evolving understanding in HIV and non-HIV immunosuppressed patients.

Expert review of ophthalmology·2025
Same journal

Systemic and Ocular Associations of Keratoconus.

Expert review of ophthalmology·2024
Same journal

How Genome-Wide Association Studies Transform Care for Patients at Risk of Glaucoma.

Expert review of ophthalmology·2024
See all related articles

Related Experiment Video

Updated: May 31, 2026

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents
10:10

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

Published on: February 15, 2022

Stem cell therapy for glaucoma: possibilities and practicalities.

Thomas V Johnson1, Natalie D Bull, Keith R Martin

  • 1Cambridge Centre for Brain Repair, University of Cambridge ED Adrian Building Forvie Site, Robinson Way, Cambridge, CB2 OPY, UK.

Expert Review of Ophthalmology
|June 21, 2011
PubMed
Summary
This summary is machine-generated.

Stem cell transplantation offers a promising approach to treating glaucoma, a degenerative optic neuropathy. This therapy aims to protect vision and replace damaged cells, addressing current treatment limitations.

More Related Videos

Subretinal Injection of Gene Therapy Vectors and Stem Cells in the Perinatal Mouse Eye
05:09

Subretinal Injection of Gene Therapy Vectors and Stem Cells in the Perinatal Mouse Eye

Published on: November 25, 2012

Related Experiment Videos

Last Updated: May 31, 2026

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents
10:10

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

Published on: February 15, 2022

Subretinal Injection of Gene Therapy Vectors and Stem Cells in the Perinatal Mouse Eye
05:09

Subretinal Injection of Gene Therapy Vectors and Stem Cells in the Perinatal Mouse Eye

Published on: November 25, 2012

Area of Science:

  • Ophthalmology
  • Neuroscience
  • Regenerative Medicine

Background:

  • Glaucoma is a progressive optic neuropathy causing irreversible vision loss.
  • Current therapies for glaucoma cannot halt or reverse neurodegeneration.
  • Stem cell transplantation presents a potential novel therapeutic strategy.

Purpose of the Study:

  • To explore stem cell transplantation for glaucoma treatment.
  • To critically discuss neuroprotection and retinal ganglion cell replacement as therapeutic modalities.
  • To identify challenges and strategies for clinical translation.

Main Methods:

  • Review of stem cell transplantation applications in glaucoma.
  • Critical analysis of neuroprotective and cell replacement strategies.
  • Identification of translational hurdles and potential solutions.

Main Results:

  • Stem cell transplantation holds promise for glaucoma treatment.
  • Two primary modalities include neuroprotection and retinal ganglion cell replacement.
  • Significant questions and obstacles remain for clinical application.

Conclusions:

  • Stem cell therapy is a potential future treatment for glaucoma.
  • Further research is needed to address safety, efficacy, and delivery.
  • Overcoming translational challenges is crucial for clinical success.